Trials / Recruiting
RecruitingNCT06388174
Idiopathic Generalized Epilepsy Syndromes
Idiopathic Generalized Epilepsy Syndromes: Clinical Features and Long-term Outcomes
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Shen Chun-Hong · Academic / Other
- Sex
- All
- Age
- 4 Years – 40 Years
- Healthy volunteers
- —
Summary
The idiopathic generalized epilepsies (IGEs) have historically included the syndromes childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and epilepsy with generalized tonic-clonic seizures alone (GTCA). Recognition of the IGEs is important for clinical care, as it informs diagnosis, prevents unnecessary investigation, allows optimal selection of anti-seizure medications (ASMs), and provides prognostic guidance. According to the new ILAE definition in 2022, the study aims to describe the clinical features, electroencephalographic, imaging findings and long-term prognosis.
Detailed description
the Long-term prognosis include the rate of drug-resistent epilepsy, relapse after drug withdrawn, common comorbidities such as mood disorders, attention deficit hyperactivity disorder (ADHD) and learning disabilities.
Conditions
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2026-12-31
- Completion
- 2033-12-31
- First posted
- 2024-04-29
- Last updated
- 2025-08-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06388174. Inclusion in this directory is not an endorsement.